Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.87 USD
0.29%
Market Closed
Updated:
May 16, 2024
Amneal Pharmaceuticals Inc
Research & Development
|
Amneal Pharmaceuticals Inc
Research & Development Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Research & Development
-$164m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Research & Development
-$15.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Research & Development
-$9.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Pfizer Inc
NYSE:PFE
|
Research & Development
-$10.6B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Research & Development
-$29.5B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-15%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Research & Development
-$9.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
See Also
What is Amneal Pharmaceuticals Inc's Research & Development?
Research & Development
-164m
USD
-164m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Research & Development amounts to -164m USD.
What is Amneal Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-9%
-9%
Over the last year, the Research & Development growth was 16%. The average annual Research & Development growth rates for Amneal Pharmaceuticals Inc have been 3% over the past three years , 3% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
